This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

DentalEZ® Group, Henry Schein And The Oral Cancer Foundation Provide Free Oral Cancer Screenings At 2013 Chicago Midwinter Dental Meeting

MALVERN, Pa. , Feb. 18, 2013 /PRNewswire/ -- DentalEZ ® Group, a supplier of innovative products and services for dental health professionals worldwide, has teamed up with Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to dental, medical and animal health practitioners, and the Oral Cancer Foundation in order to provide free oral cancer screenings at this year's Chicago Midwinter Dental Meeting.  

The screenings will take place on Thursday, February 21, and Friday, February 22, from 10 a.m. - 4 p.m.; and on Saturday, February 23, from 10 a.m. to 3:30 p.m., at Henry Schein's Total Health booth # 2321 located on the main exhibit floor.   Volunteers from the Oral Cancer Foundation will administer the screenings using the Identafi ® oral cancer screening device, a product of the DentalEZ Group's StarDental ® division.

Since being selected as the exclusive global distributor of the Identafi in late 2012, Henry Schein has made the Identafi a core component of its Total Health Beyond The Mouth initiative.   The Total Health Beyond the Mouth program is an integrated wellness and education program that informs patients of the integral link between oral health and total health, and assists dental professionals in uncovering potential systemic health problems, including periodontal disease, oral cancer, sleep disorders, heart disease, and diabetes.

"We are pleased with the active role that both Henry Schein and the Oral Cancer Foundation have assumed to advocate for the early screening of oral cancer," remarked Rick Gross, Senior Product Manager for StarDental.   "By working together on initiatives such as this, we can advance this important public health issue and communicate the exceptional benefits of our system.   And what better location to further remind and educate dental professionals about the importance of early detection than at the Chicago Dental Society's Midwinter Dental Meeting."

Identafi is an oral cancer screening device used for the detection of oral pathologies, including biochemical and morphological changes in the cells of the mouth, throat, tongue, and tonsils that may lead to oral cancer.   The small, cordless, handheld device uses an innovative 3-wavelength optical illumination and visualization system that allows dental professionals to identify oral mucosal abnormalities not visible to the naked eye.

To receive your free oral cancer screening, please visit booth #2321 at this year's Chicago Midwinter Dental Meeting.  

For additional information on the Identafi and all DentalEZ products and services, please call 866-DTE-INFO or visit .    

About DentalEZ ® Group

DentalEZ ® Group is committed to advancing the practice of dentistry through innovative products and services.   Encompassing six distinct product brands — StarDental ®, DentalEZ ®, CustomAir ®, RAMVAC ®, NevinLabs , and Columbia Dentoform ® — DentalEZ ® Group manufactures everything in the operatory, from handpieces to chairs to vacuum systems to dental simulation models, creating a complete line of products to elevate the health, comfort, and efficiency of the dental operatory.   For more information, please visit

SOURCE DentalEZ Group

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs